Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of September 2017, with the report filed on October 10, 2017. The document serves as a disclosure of securities and derivatives transactions involving the company's Board of Directors, Management, and related persons, in compliance with Article 11 of CVM Instruction # 358/2002.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It exclusively details insider trading activity.
| Group | Transaction Type | Securities | Quantity | Total Volume (R$) |
|---|---|---|---|---|
| Board of Directors | Buy | Call Options (ABEVI2 ON) | 30,000 | 60,990.00 |
| Board of Directors | Sell | Common Shares | 12,775 | 268,978.83 |
| Board of Directors | Final Balance | Common Shares | 5,543,923 | - |
| Board of Directors | Final Balance | ADR Common | 336,300 | - |
| Management | Activity | None | 0 | 0.00 |
| Management | Final Balance | Common Shares | 7,225 | - |
Material Changes
For the Board of Directors, the net change in common share holdings was a reduction of 12,775 shares. The group also acquired 30,000 call options (ABEVI2 ON) during the period. The Management group reported no transactions, maintaining a static balance of 7,225 common shares.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of insider trading positions and transactions.
Investor Verification Checklist
- Verify the specific identities of the Board members who executed the 12,775 share sales and 30,000 option purchases.
- Confirm the strike price and expiration date of the ABEVI2 ON call options purchased by the Board.
- Review the company's broader 20-F or 40-F filings for actual financial performance metrics, as this 6-K contains none.
- Check if the sold shares were part of a pre-arranged trading plan (Rule 10b5-1 equivalent) or discretionary sales.